Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
t-PA (Monteplase) injection during vitrectomy for central retinal artery occlusion
jRCTs041190079Recruiting
- Start
- Mar 2020
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of monteplase in central retinal artery occlusion (CRAO). Primary endpoint: Visual acuity at 12 weeks after the first operation. Started Mar 2020; status: recruiting.
02
Drugs
monteplase
03
Conditions
central retinal artery occlusion (CRAO)
Beyond the preview
Go deeper on jRCTs041190079.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190079.